Last quarter Eli Lilly (NYSE:LLY) beat estimates by 14 cents per share and it is up again on Wednesday, July 25, 2012.
Continue Reading Below
Analysts currently expect Eli Lilly to come in with earnings of 77 cents per share on revenues of $5.58 billion. Analyst estimates range from earnings per share to earnings per share. Over the past three months, the average estimate has moved up from 72 cents.
In terms of price changes, the stock's best recent streak was when it gained $1.71 per share between July 11, 2012 and July 18, 2012. Looking at change over the last three months, from April 23, 2012 and July 18, 2012, the stock price is up $4.70 (11.8%), from $39.81 to $44.51.
Company Fundamental Trends The company will look to use the upcoming earnings announcement as a salve for two-straight quarters of revenue declines. Revenue decreased by 2.3% during the past fourth quarter of the last fiscal year and dropped further over the first quarter. Profit has fallen by a year-over-year average of 11.8% during the previous four quarters, and the company is will try to reverse trend of recent drops in profit leading up to this earnings announcement.
Analysts think investors should stand pat on Eli Lilly with 12 of 17 analysts rating it hold. Analyst sentiment has been improving recently, as the average rating risen slightly over the past three months.
Last Quarter's Results
In the first quarter, profit fell 4.2% to $1.01 billion (91 cents a share) from $1.06 billion (95 cents a share) the year earlier, but exceeded analyst expectations. Revenue fell 4.1% to $5.6 billion from $5.84 billion.
Reporting Period: 2Q
Date of Release: Wednesday, July 25, 2012 before market open
EPS: 77 cents
Revenue Estimate: $5.58 billion
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)